Brief: Japan's Asahi Kasei Corp: To Acquire Sweden's Calliditas Therapeutics AB For Total Equity Value Of About SEK 11.8 Billion (About JPY 174 Billion)
May 28 (Reuters) - Asahi Kasei Corp 3407.T :
* ASAHI KASEI CORP - ASAHI KASEI TO ACQUIRE CALLIDITAS
THERAPEUTICS AB
* ASAHI KASEI CORP - TO ACQUIRE SWEDEN'S CALLIDITAS
THERAPEUTICS
AB FOR TOTAL EQUITY VALUE OF ABOUT SEK 11.8 BILLION (ABOUT JPY
174 BILLION)
* ASAHI KASEI CORP - TO OFFER SEK 208 PER SHARE TO
SHAREHOLDERS OF
CALLIDITAS AND SEK 416 TO HOLDERS OF AMERICAN DEPOSITARY SHARES
OF CALLIDITAS
Source text for Eikon: ID:nTSqb7c628
Further company coverage: 3407.T
(Reporting by Kantaro Komiya)
((Kantaro.Komiya@thomsonreuters.com;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations